118 related articles for article (PubMed ID: 24009229)
1. Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherin-restricted miRNA antagonists of miR-27.
Young JA; Ting KK; Li J; Moller T; Dunn L; Lu Y; Moses J; Prado-Lourenço L; Khachigian LM; Ng M; Gregory PA; Goodall GJ; Tsykin A; Lichtenstein I; Hahn CN; Tran N; Shackel N; Kench JG; McCaughan G; Vadas MA; Gamble JR
Blood; 2013 Oct; 122(16):2911-9. PubMed ID: 24009229
[TBL] [Abstract][Full Text] [Related]
2. Targeting miR-27a/VE-cadherin interactions rescues cerebral cavernous malformations in mice.
Li J; Zhao Y; Choi J; Ting KK; Coleman P; Chen J; Cogger VC; Wan L; Shi Z; Moller T; Zheng X; Vadas MA; Gamble JR
PLoS Biol; 2020 Jun; 18(6):e3000734. PubMed ID: 32502201
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
[TBL] [Abstract][Full Text] [Related]
4. microRNA-125b inhibits tube formation of blood vessels through translational suppression of VE-cadherin.
Muramatsu F; Kidoya H; Naito H; Sakimoto S; Takakura N
Oncogene; 2013 Jan; 32(4):414-21. PubMed ID: 22391569
[TBL] [Abstract][Full Text] [Related]
5. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-22 regulates inflammation and angiogenesis via targeting VE-cadherin.
Gu W; Zhan H; Zhou XY; Yao L; Yan M; Chen A; Liu J; Ren X; Zhang X; Liu JX; Liu G
FEBS Lett; 2017 Feb; 591(3):513-526. PubMed ID: 28112401
[TBL] [Abstract][Full Text] [Related]
7. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
[TBL] [Abstract][Full Text] [Related]
8. Vitronectin increases vascular permeability by promoting VE-cadherin internalization at cell junctions.
Li R; Ren M; Chen N; Luo M; Zhang Z; Wu J
PLoS One; 2012; 7(5):e37195. PubMed ID: 22606350
[TBL] [Abstract][Full Text] [Related]
9. Nitric Oxide Increases Arterial Endotheial Permeability through Mediating VE-Cadherin Expression during Arteriogenesis.
Yang B; Cai B; Deng P; Wu X; Guan Y; Zhang B; Cai W; Schaper J; Schaper W
PLoS One; 2015; 10(7):e0127931. PubMed ID: 26133549
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Tat C modulates expression of miRNA-101 to suppress VE-cadherin in human brain microvascular endothelial cells.
Mishra R; Singh SK
J Neurosci; 2013 Apr; 33(14):5992-6000. PubMed ID: 23554480
[TBL] [Abstract][Full Text] [Related]
11. Exosomal miR-22-3p Derived from Chronic Rhinosinusitis with Nasal Polyps Regulates Vascular Permeability by Targeting VE-Cadherin.
Zhang W; Zhang T; Yan Y; Zhang J; Zhou Y; Pei Y; Yao L; You B; Chen J
Biomed Res Int; 2020; 2020():1237678. PubMed ID: 33274193
[TBL] [Abstract][Full Text] [Related]
12. VE-cadherin Y685F knock-in mouse is sensitive to vascular permeability in recurrent angiogenic organs.
Sidibé A; Polena H; Pernet-Gallay K; Razanajatovo J; Mannic T; Chaumontel N; Bama S; Maréchal I; Huber P; Gulino-Debrac D; Bouillet L; Vilgrain I
Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H455-63. PubMed ID: 24858856
[TBL] [Abstract][Full Text] [Related]
13. Rab11a Mediates Vascular Endothelial-Cadherin Recycling and Controls Endothelial Barrier Function.
Yan Z; Wang ZG; Segev N; Hu S; Minshall RD; Dull RO; Zhang M; Malik AB; Hu G
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):339-49. PubMed ID: 26663395
[TBL] [Abstract][Full Text] [Related]
14. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
[TBL] [Abstract][Full Text] [Related]
15. Serum exosomal miR-638 is a prognostic marker of HCC via downregulation of VE-cadherin and ZO-1 of endothelial cells.
Yokota Y; Noda T; Okumura Y; Kobayashi S; Iwagami Y; Yamada D; Tomimaru Y; Akita H; Gotoh K; Takeda Y; Tanemura M; Murakami T; Umeshita K; Doki Y; Eguchi H
Cancer Sci; 2021 Mar; 112(3):1275-1288. PubMed ID: 33426736
[TBL] [Abstract][Full Text] [Related]
16. A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis.
Hou S; Niu G; Liu X; Bourbon PM; Zhang D; Cui P; Zhao K; Zhao D; Zeng H
Microvasc Res; 2021 Nov; 138():104209. PubMed ID: 34146582
[TBL] [Abstract][Full Text] [Related]
17. Interference With ESAM (Endothelial Cell-Selective Adhesion Molecule) Plus Vascular Endothelial-Cadherin Causes Immediate Lethality and Lung-Specific Blood Coagulation.
Duong CN; Nottebaum AF; Butz S; Volkery S; Zeuschner D; Stehling M; Vestweber D
Arterioscler Thromb Vasc Biol; 2020 Feb; 40(2):378-393. PubMed ID: 31826650
[TBL] [Abstract][Full Text] [Related]
18. Losartan protects against myocardial ischemia and reperfusion injury
Li Y; Yao Y; Li J; Chen Q; Zhang L; Wang QK
FASEB J; 2019 Jul; 33(7):8555-8564. PubMed ID: 30991833
[TBL] [Abstract][Full Text] [Related]
19. The role of VE-cadherin in vascular morphogenesis and permeability control.
Dejana E; Vestweber D
Prog Mol Biol Transl Sci; 2013; 116():119-44. PubMed ID: 23481193
[TBL] [Abstract][Full Text] [Related]
20. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis.
Liu P; Jia SB; Shi JM; Li WJ; Tang LS; Zhu XH; Tong P
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988072
[No Abstract] [Full Text] [Related]
[Next] [New Search]
